According to GlaxoSmithKline Pharmaceuticals latest financial reports the company had earnings of $72.86M in 2023-03-31, an decrease of -63.97% to 2022.
Year | Earnings | Change |
---|---|---|
2023 | $72.86M | -63.97% |
2022 | $202.20M | 373.19% |
2021 | $42.73M | 284.26% |
2020 | $11.12M | - |